Schedule 13G ownership disclosure

Onconova Therapeutics Inc

Security class unavailable · CUSIP: 68232V306

Event date: 2019-11-08

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
499,041
Percent of class
6.1000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000905718-19-000947
Form type
SC 13G/A
Filer
Traws Pharma, Inc.
CIK
CIK 1130598
Filed
Nov 18, 2019
Reporting period
Nov 08, 2019
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub